ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Advanced/Metastatic NSCLC With PD-L1 ≥ 50% and Without Actionable Genomic Alterations
By
ASCO 2022 Conference Coverage
FEATURING
Benjamin Levy
By
ASCO 2022 Conference Coverage
FEATURING
Benjamin Levy
131 views
June 10, 2022
Comments 0
Login to view comments.
Click here to Login
Lung